Coronary Artery Calcium Scores After Prophylactic Premenopausal Bilateral Salpingo-Oophorectomy
Beekman, Maarten J.; Terra, Lara; Heemskerk-Gerritsen, Bernadette A.M.; van der Aalst, Carlijn M.; Roeters van Lennep, Jeanine E.; van Beurden, Marc; van Doorn, Helena C.; de Hullu, Joanne A.; van Dorst, Eleonora B.L.; Mom, Constantijne H.; Mourits, Marian J.E.; Slangen, Brigitte F.M.; Bartels-Rutten, Annemarieke; Budde, Ricardo P.J.; Snoeren, Miranda M.; Leiner, Tim; de Jong, Pim A.; Vliegenthart, Rozemarijn; Planken, R. Nils; Mihl, Casper; Vonder, Marleen; Oudkerk, Matthijs; Gaarenstroom, Katja N.; Gratama, Jan Willem C.; van Engelen, Klaartje; van der Kolk, Lizet E.; Collée, J. Margriet; Wevers, Marijke R.; Ausems, Margreet G.E.M.; Berger, Lieke P.V.; Gomez Garcia, Encarna B.; van Asperen, Christi J.; Hooning, Maartje J.; de Koning, Harry J.; Maas, Angela H.E.M.; van Leeuwen, Flora E.
(2024) JACC: CardioOncology, volume 6, issue 6, pp. 922 - 931
(Article)
Abstract
Background: Premenopausal risk-reducing salpingo-oophorectomy (RRSO) in women at high familial risk of ovarian cancer leads to immediate menopause. Although early natural menopause is associated with increased cardiovascular disease risk, evidence on long-term cardiovascular disease risk after early surgical menopause is scarce. Objectives: We sought to determine the long-term influence of
... read more
the timing of RRSO on the development of coronary artery calcium (CAC), an established marker for cardiovascular disease risk. Methods: We conducted a cross-sectional study (N = 733) nested in a nationwide cohort of women at high familial risk of ovarian cancer. In women aged 60-70 years (n = 328), we compared CAC scores between women with a premenopausal RRSO (age ≤45 years) and women with a postmenopausal RRSO (age ≥54 years), using multivariable Poisson analyses. Within the premenopausal RRSO group (n = 498), we also examined the effect of age at RRSO. In addition, we compared the premenopausal RRSO group with an external reference cohort (n = 5,226). Results: Multivariable analyses showed that the prevalence rates of any CAC (CAC >0), at least moderate CAC (CAC >100), and severe CAC (CAC >400) were comparable between the premenopausal and postmenopausal RRSO groups (relative risk [RR]: 0.93; 95% CI: 0.75-1.15 for any CAC; RR: 0.71; 95% CI: 0.43-1.17 for at least moderate CAC; RR: 0.81; 95% CI: 0.30-2.13 for severe CAC). There was no difference in CAC between the premenopausal RRSO group and a similar aged reference cohort. Timing of premenopausal RRSO (early premenopausal RRSO [<41 years] vs late premenopausal RRSO [41-45 years]) did not affect the outcomes. Conclusions: Our results do not show a long-term adverse effect of surgical menopause on the development of CAC.
show less
Download/Full Text
Keywords: BRCA, CAC, cardiovascular disease, ovarian cancer, RRSO, surgical menopause, Oncology, Cardiology and Cardiovascular Medicine
ISSN: 2666-0873
Publisher: Elsevier
Note: Publisher Copyright: © 2024 The Authors
(Peer reviewed)